BlackRock Keeps Compounding Scale, but the Stock Is No Longer Cheap

Written by Julia Rostova

BlackRock delivered the kind of quarter that reminds investors why scale in asset management can become a compounding moat instead of a mere size statistic. The company reported $7.084 billion in revenue for the second quarter of 2026, up 31% year over year, while GAAP net income reached $1.914 billion and diluted EPS rose to $12.19. Adjusted diluted EPS came in at $13.91, assets under management climbed to $15.344 trillion, and total net inflows reached $191.7 billion. Adjusted operating margin improved to 45.9%. In other words, BlackRock did not merely post a strong quarter. It showed again that in its business, flows, scale, technology, and operating leverage reinforce one another.

That is the franchise case in one sentence. BlackRock is no longer just an asset manager that happens to be very large. It is a financial infrastructure company whose scale makes its distribution, product mix, and technology harder for competitors to match. When the firm posts big inflows, those assets do not only lift fee-bearing AUM. They also support a broader machine that includes ETFs, active capabilities, institutional relationships, and technology services that deepen client dependence.

The problem for new buyers is that the market already understands this. On Finviz, BlackRock trades at $1,093.40 against a consensus target price of $1,311.13, which implies roughly 19.9% upside. That is meaningful enough to keep the stock interesting, but it is not the kind of discount that makes the shares obviously mispriced after such a strong operating performance. The company also commands a premium valuation, with a P/E of 26.82x, forward P/E of 17.16x, P/S of 6.44x, and P/B of 3.14x. Those numbers are not irrational given the quality of the franchise, but they do mean investors are already paying for excellence.

My verdict on BLK is HOLD with a $1,300 price target. The business deserves patience. The stock no longer offers the kind of neglect that would justify a more aggressive rating.

The bull case for BlackRock is still powerful. The company’s second-quarter numbers show that it can translate scale into better economics instead of bureaucratic drag. AUM growth of 22% to more than $15.3 trillion is impressive on its own, but the more important point is how much revenue and margin came through with it. Strong long-term net inflows and a rising operating margin suggest the firm is not just collecting more assets. It is monetizing them efficiently.

That matters because BlackRock has one of the rarest qualities in financial services: multiple reinforcing engines. The ETF franchise drives flows and client relevance. The institutional platform deepens distribution. The technology layer, including the broader Aladdin logic around embedded workflow dependence, strengthens the competitive moat. When a firm has that many mutually reinforcing parts, it can deserve a premium for long stretches.

But deserving a premium and being a compelling buy today are different questions. At the current price, BlackRock looks more like a high-quality compounder than a glaring value opportunity. Investors can still do well owning it, yet the easy money from discovering the business quality is already gone.

Apollo is the most interesting comparable because it offers more upside with a more complicated earnings profile. The stock trades at $121.83 against a consensus target price of $150.65, implying about 23.7% upside. The surface-level valuation looks strange, with a P/E of 80.11x, but the forward multiple drops to 11.46x, reflecting the market’s expectation of a much stronger earnings path ahead. Apollo’s P/S of 2.22x is far below BlackRock’s, and the stock is down 15.8% year to date, which means the market has already imposed some caution. My verdict on APO is BUY with a $150 price target. It offers more upside than BlackRock for investors willing to accept greater complexity and a less polished profitability profile.

T. Rowe Price illustrates the opposite problem. On conventional metrics, it does not look expensive. The stock trades at 12.71x earnings, 11.38x forward earnings, and 2.36x book, while profit margin of 27.59% and operating margin of 35.84% still look strong. Yet the consensus target price of $107.75 sits about 9.1% below the current $118.58 share price. That tells you something important. A respectable legacy asset manager can still be overvalued if the market pays up faster than the strategic narrative improves. My verdict on TROW is SELL with a $108 price target.

The risk to the BlackRock thesis is not hard to identify. Premium franchises can still underperform if expectations get ahead of what the next several quarters can realistically deliver. If flows moderate, market levels soften, or investors decide that the premium multiple is rich enough, BLK can become a good business with mediocre near-term stock returns. That is not a broken thesis. It is simply the cost of quality being widely recognized.

This is where the capacity-to-suffer framework matters. BlackRock looks like a business investors can deserve to hold through noise because the franchise is not dependent on a fragile single-cycle story. But holding a great business patiently is different from chasing it indiscriminately. My conclusion is that BLK remains a HOLD at $1,300: admirable, durable, and still attractive, but no longer cheap. Apollo is the more compelling BUY at $150 because the upside is larger and the market has been less generous. T. Rowe Price is a SELL at $108 because a profitable model alone is not enough when the stock already looks ahead of its fair value. BlackRock keeps compounding scale. The current valuation simply suggests investors should respect it more than rush into it.

*This article is for informational and educational purposes only and is not financial advice. Investors should do their own due diligence, consider their risk tolerance, and remember that past performance does not guarantee future results.*